🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/02/2001 | 73,57 | 75,86 | 73,19 | 75,70 | +2,92% | 3,63% | 4.406.840 |
| 23/02/2001 | 73,52 | 74,36 | 73,19 | 73,55 | -0,80% | 1,60% | 5.378.336 |
| 22/02/2001 | 75,11 | 75,30 | 73,09 | 74,14 | -1,28% | 2,93% | 5.436.081 |
| 21/02/2001 | 75,09 | 75,95 | 74,89 | 75,11 | +1,04% | 1,42% | 4.478.838 |
| 20/02/2001 | 73,77 | 74,83 | 73,52 | 74,33 | +0,79% | 1,77% | 4.544.233 |
| 16/02/2001 | 73,95 | 74,62 | 73,36 | 73,75 | -1,04% | 1,70% | 6.039.414 |
| 15/02/2001 | 74,43 | 74,67 | 72,90 | 74,52 | -1,92% | 2,37% | 8.212.338 |
| 14/02/2001 | 76,62 | 77,03 | 75,97 | 75,98 | -1,39% | 1,38% | 3.941.004 |
| 13/02/2001 | 78,48 | 78,94 | 75,89 | 77,05 | -2,69% | 3,89% | 6.080.077 |
| 12/02/2001 | 79,17 | 79,47 | 78,29 | 79,18 | +0,31% | 1,48% | 3.992.146 |
| 09/02/2001 | 79,10 | 79,17 | 78,30 | 78,93 | -0,30% | 1,10% | 4.109.208 |
| 08/02/2001 | 77,15 | 80,15 | 76,11 | 79,17 | +1,37% | 5,24% | 10.485.135 |
| 07/02/2001 | 80,51 | 80,89 | 77,86 | 78,10 | -2,98% | 3,76% | 8.175.238 |
| 06/02/2001 | 80,62 | 80,99 | 80,15 | 80,50 | -0,14% | 1,04% | 3.771.123 |
| 05/02/2001 | 80,12 | 81,63 | 80,12 | 80,61 | +0,61% | 1,88% | 3.141.380 |
| 02/02/2001 | 80,63 | 81,41 | 79,72 | 80,12 | -0,60% | 2,09% | 4.449.808 |
| 01/02/2001 | 78,96 | 80,61 | 78,42 | 80,61 | +2,80% | 2,78% | 5.279.300 |
| 31/01/2001 | 77,10 | 79,20 | 76,15 | 78,42 | +1,46% | 3,96% | 6.249.958 |
| 30/01/2001 | 77,19 | 77,77 | 76,35 | 77,29 | +0,86% | 1,84% | 3.846.579 |
| 29/01/2001 | 78,53 | 79,63 | 76,15 | 76,63 | -2,36% | 4,44% | 4.289.988 |
| 26/01/2001 | 78,96 | 80,15 | 78,18 | 78,48 | +0,46% | 2,49% | 5.546.330 |
| 25/01/2001 | 75,92 | 78,24 | 75,80 | 78,13 | +3,72% | 3,22% | 7.649.562 |
| 24/01/2001 | 76,10 | 76,34 | 75,02 | 75,32 | -0,79% | 1,72% | 8.815.776 |
| 23/01/2001 | 77,17 | 77,17 | 74,96 | 75,92 | -3,34% | 2,86% | 11.981.679 |
| 22/01/2001 | 79,79 | 79,79 | 78,36 | 78,54 | -0,15% | 1,79% | 4.609.418 |
| 19/01/2001 | 78,36 | 79,85 | 78,36 | 78,66 | -0,53% | 1,90% | 5.638.659 |
| 18/01/2001 | 77,77 | 80,15 | 77,65 | 79,08 | +2,00% | 3,22% | 5.440.378 |
| 17/01/2001 | 79,20 | 79,50 | 77,29 | 77,53 | -2,48% | 2,79% | 6.769.032 |
| 16/01/2001 | 77,65 | 80,57 | 76,81 | 79,50 | +2,30% | 4,84% | 5.764.943 |
| 12/01/2001 | 78,13 | 79,50 | 77,29 | 77,71 | -0,23% | 2,82% | 5.280.453 |